Key points are not available for this paper at this time.
In the last decade there has been an increase in the development and marketing of digital therapeutic (DTx) products aiming to prevent, manage, or treat a medical disorder or disease. Health insurance coverage for these products is not well established, and payers are facing increasing pressure to include these products as a covered benefit.
Gomez‐Lumbreras et al. (Sun,) studied this question.